Hospice increase doesn't offset end-of-life care for ovarian cancer

This article originally appeared here.
Hospice increase doesn't offset end-of-life care for ovarian cancer
Hospice increase doesn't offset end-of-life care for ovarian cancer

(HealthDay News) -- Increasing use of hospice in the final days of ovarian cancer does not offset intensive end-of-life care in older women, according to a study published online Oct. 6 in the Journal of Clinical Oncology.

Alexi A. Wright, M.D., from the Dana-Farber Cancer Institute in Boston, and colleagues examined changes in medical care during the last month of life over time for 6,956 individuals (aged ≥66 years) enrolled in fee-for-service Medicare. Patients were diagnosed with epithelial ovarian cancer between 1997 and 2007, and died as a result of ovarian cancer by December 2007.

The researchers found that between 1997 and 2007, hospice use increased significantly, and terminal hospitalizations decreased (both P < 0.001). There was, however, a simultaneous, statistically significant increase in intensive care unit admissions, hospitalizations, repeated emergency department visits, and health care transitions (all P ≤ 0.01). Over time the proportion of patients referred to hospice from inpatient settings rose (P = 0.001). Compared to outpatients, inpatients referred to hospice were more likely to enroll in hospice within three days of death (adjusted odds ratio, 1.36).

"Use of hospital-based services increased over time, and patients underwent more transitions among health care settings near death, suggesting that the increasing use of hospice did not offset intensive end-of-life care," the authors write.

Abstract
Full Text (subscription or payment may be required)

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs